| 1 |
35387260 | Exploring the Resistance Mechanisms of Distal D835V Mutation in FLT3 to Inhibitors. | 2022 |
2 |
| 2 |
29137311 | Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia. | 2017 Oct 10 |
1 |
| 3 |
24255108 | FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice. | 2013 Dec 24 |
3 |
| 4 |
21332708 | Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations. | 2011 Apr |
1 |
| 5 |
19540337 | Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. | 2009 Dec |
1 |
| 6 |
14977832 | Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: a comparative analysis of 120 paired diagnostic and relapse bone marrow samples. | 2004 Feb 15 |
4 |
| 7 |
15352981 | FLT3 mutations in myeloid sarcoma. | 2004 Sep |
2 |
| 8 |
12707374 | Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay. | 2003 May |
1 |
| 9 |
12239147 | Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. | 2002 Oct 1 |
1 |